Sectors

Lab-grown milk is becoming commercially viable — and studies have shown that consumers aren’t averse to it. So, is it time for corporate investors to back these startups?

David Neustaedter, the 14-year corporate venturing veteran, has left his VP position at Medtronic and joined an undisclosed investment firm.

Reliance Egypt participated in Trukker’s $100m series C round while Merck, Eli Lilly and Heritage Medical all backed Photys’ $75m series A.

SoftBank, Bristol Myers Squibb and Hitachi were among Arsenal Biosciences’ $220m round while MegaChips led a $140m round for Morse Micro.

With three health corporate LPs in tow, Kortex Ventures’ focus is digital and personalised.

SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.

The move comes as Schenker Ventures seeks to further expand its investment team

Charbel Rizk has spun Oculi out of Johns Hopkins University to commercialise technology that gives computer vision the capabilities of the human eye.

These are the 55 women working in corporate venturing function across the DACH region — and how they got there.

After two years at venture firm Verve Ventures, João Duarte has taken up a Switzerland-based senior manager role at eBay Ventures.

Eli Lilly took part in a $50m series A1 round for Neukio Biotherapeutics while Itochu led Docquity’s $44m series C.